To more directly investigate the involvement of BCR::ABL1 in higher CD49f expression levels in Ph‐positive leukemia cells, we analyzed two pairs of Ph‐positive ALL cell lines, that is, the parental lines and their T315I acquired imatinib‐resistant sublines. This evidence concerns the gene BCR and acute lymphoblastic leukemia.